Trump Nominates Erica Schwartz to Lead CDC Amid Vaccine Policy Turmoil

President Donald Trump on Thursday nominated Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC), concluding a months-long search for a permanent director. Schwartz, a former rear admiral and chief medical officer of the Coast Guard, previously served as deputy surgeon general during Trump's first administration, where she was central to the U.S. response to the Covid-19 pandemic. The nomination comes as the agency faces significant internal turmoil under HHS Secretary Robert F. Kennedy Jr. The CDC has been characterized by plummeting morale and high staff turnover, further exacerbated by a security incident at its Atlanta headquarters last August. The agency has also struggled with leadership continuity; the tenure of acting director Dr. Jay Bhattacharya recently expired under the Vacancies Act, which limits acting officers to 210 days. A primary point of contention remains the overhaul of childhood vaccine recommendations. Recent efforts to reduce the number of recommended childhood shots from 17 to 11 were blocked by a judge. While Schwartz's specific views on these policies remain unclear, her appointment is seen as a move toward permanent leadership after the brief tenure of Dr. Susan Monarez, who was fired last summer. Alongside Schwartz, the administration nominated Sean Slovenski as deputy director and chief operating officer, and Jennifer Shuford as deputy director and chief medical officer. Shuford previously led the Texas Department of State Health Services, where she managed a major measles outbreak. Market participants in the healthcare and pharmaceutical sectors are monitoring these appointments closely, as the CDC's immunization policies directly influence vaccine demand and regulatory standards. Public trust in federal health agencies has reportedly declined across the political spectrum during Secretary Kennedy's tenure.